Literature DB >> 15148207

Nitric oxide proxies and ocular perfusion pressure in primary open angle glaucoma.

F Galassi1, G Renieri, A Sodi, F Ucci, L Vannozzi, E Masini.   

Abstract

BACKGROUND: To investigate the levels of nitric oxide (NO) markers in plasma and aqueous humour of patients with primary open angle glaucoma (POAG) and their relation to ocular perfusion pressure.
METHODS: Cyclic guanosine monophosphate (cGMP) and nitrite (NO(2)(-)) were determined in plasma and aqueous humour of 38 patients with POAG and 46 controls. Blood pressure and IOP were measured to calculate ocular perfusion pressure (PP).
RESULTS: cGMP and NO(2)(-) plasma levels were significantly decreased in glaucoma patients compared with controls (p = 0.001 v p = 0.004). In the aqueous humour of subjects with POAG, cGMP and NO(2)(-) concentrations were also lower than in normal eyes (p = 0.0001 v p = 0.001). There was a linear association between cGMP in plasma and aqueous humour in glaucomas and controls (r = 0.514, p = 0.029 and r = 0.558, p = 0.004) and this relation differed in the two groups (p = 0.003). Considering glaucoma patients with controls, a positive correlation was found between cGMP and PP (r = 0.379, p = 0.01) and between NO(2)(-) and PP (r = 0.339, p = 0.040). The cGMP/PP correlation was of borderline statistical significance in controls (p = 0.050), whereas it did not attain statistical significance in POAG, as well as the association between NO(2)(-) and PP when glaucomas and controls were considered separately.
CONCLUSIONS: The authors found alterations of NO markers in the plasma and aqueous humour of glaucoma patients. Primary or secondary impaired NO balance could alter ocular perfusion pressure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15148207      PMCID: PMC1772173          DOI: 10.1136/bjo.2003.028357

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  34 in total

1.  Decreased nitric oxide production in primary open-angle glaucoma.

Authors:  S Doganay; C Evereklioglu; Y Turkoz; H Er
Journal:  Eur J Ophthalmol       Date:  2002 Jan-Feb       Impact factor: 2.597

2.  Ocular haemodynamics and nitric oxide in normal pressure glaucoma.

Authors:  F Galassi; A Sodi; F Ucci; G Renieri; B Pieri; E Masini
Journal:  Acta Ophthalmol Scand Suppl       Date:  2000

3.  The effect of L-arginine on intraocular pressure in the human eye.

Authors:  H Chuman; T Chuman; N Nao-i; A Sawada
Journal:  Curr Eye Res       Date:  2000-06       Impact factor: 2.424

4.  Nebivolol induces endothelium-dependent relaxations of canine coronary arteries.

Authors:  Y S Gao; T Nagao; R A Bond; W J Janssens; P M Vanhoutte
Journal:  J Cardiovasc Pharmacol       Date:  1991-06       Impact factor: 3.105

5.  Biochemical markers of the L-arginine-nitric oxide pathway in the aqueous humour in glaucoma patients.

Authors:  Hanna Kotikoski; Eeva Moilanen; Heikki Vapaatalo; Esko Aine
Journal:  Acta Ophthalmol Scand       Date:  2002-04

6.  Effects of systemic NO synthase inhibition on choroidal and optic nerve head blood flow in healthy subjects.

Authors:  A Luksch; K Polak; C Beier; E Polska; M Wolzt; G T Dorner; H G Eichler; L Schmetterer
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-09       Impact factor: 4.799

7.  Human retinal hemodynamics following administration of 5-isosorbide mononitrate.

Authors:  A E Iannaccone; J DuPont; J E Grunwald
Journal:  Curr Eye Res       Date:  2000-03       Impact factor: 2.424

8.  Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery.

Authors:  I O Haefliger; J Flammer; T F Lüscher
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-06       Impact factor: 4.799

9.  Role of NO in choroidal blood flow regulation during isometric exercise in healthy humans.

Authors:  Alexandra Luksch; Elzbieta Polska; Andrea Imhof; Joanne Schering; Gabriele Fuchsjäger-Mayrl; Michael Wolzt; Leopold Schmetterer
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-02       Impact factor: 4.799

10.  Nitrate therapy may retard glaucomatous optic neuropathy, perhaps through modulation of glutamate receptors.

Authors:  D Zurakowski; C K Vorwerk; M Gorla; A J Kanellopoulos; N Chaturvedi; C L Grosskreutz; S A Lipton; E B Dreyer
Journal:  Vision Res       Date:  1998-05       Impact factor: 1.886

View more
  49 in total

1.  Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration.

Authors:  Lauren K Wareham; Ana C Dordea; Grigorij Schleifer; Vincent Yao; Annabelle Batten; Fei Fei; Joseph Mertz; Meredith Gregory-Ksander; Louis R Pasquale; Emmanuel S Buys; Rebecca M Sappington
Journal:  Neurobiol Dis       Date:  2018-09-10       Impact factor: 5.996

2.  Neuroprotective effect of edaravone in experimental glaucoma model in rats: a immunofluorescence and biochemical analysis.

Authors:  Arzu Toruk Aksar; Nursen Yuksel; Mustafa Gok; Mustafa Cekmen; Yusuf Caglar
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

3.  Openers of small conductance calcium-activated potassium channels selectively enhance NO-mediated bradykinin vasodilatation in porcine retinal arterioles.

Authors:  T Dalsgaard; C Kroigaard; M Misfeldt; T Bek; U Simonsen
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

4.  A topical nitric oxide-releasing dexamethasone derivative: effects on intraocular pressure and ocular haemodynamics in a rabbit glaucoma model.

Authors:  F Galassi; E Masini; B Giambene; F Fabrizi; C Uliva; M Bolla; E Ongini
Journal:  Br J Ophthalmol       Date:  2006-08-16       Impact factor: 4.638

5.  Enhanced oxygen saturation in optic nerve head of non-human primate eyes following the intravitreal injection of NCX 434, an innovative nitric oxide-donating glucocorticoid.

Authors:  Bahram Khoobehi; Valerio Chiroli; Daniela Ronchetti; Daniela Miglietta; Hillary Thompson; Ennio Ongini; Francesco Impagnatiello
Journal:  J Ocul Pharmacol Ther       Date:  2011-03-17       Impact factor: 2.671

6.  Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma.

Authors:  Ozgül Altintaş; Hale Maral; Nurşen Yüksel; V Levent Karabaş; Meltem O Dillioğlugil; Yusuf Cağlar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-02-02       Impact factor: 3.117

7.  Differences in corneal parameters between normal tension glaucoma and primary open-angle glaucoma.

Authors:  Jacky W Y Lee; Raymond L M Wong; Jonathan C H Chan; Ian Y H Wong; Jimmy S M Lai
Journal:  Int Ophthalmol       Date:  2014-11-25       Impact factor: 2.031

8.  Effects of endothelin-1 on calcium-independent contraction of bovine trabecular meshwork.

Authors:  Giulia Renieri; Lars Choritz; Rita Rosenthal; Susann Meissner; Norbert Pfeiffer; Hagen Thieme
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-10       Impact factor: 3.117

9.  Oxidant/antioxidant balance in the aqueous humor of patients with glaucoma.

Authors:  Esra Ergan; Faruk Ozturk; Emrullah Beyazyildiz; Ufuk Elgin; Emine Sen; Ali Bulent Cankaya; Tugrul Celik
Journal:  Int J Ophthalmol       Date:  2016-02-18       Impact factor: 1.779

10.  Association of eNOS and HSP70 gene polymorphisms with glaucoma in Pakistani cohorts.

Authors:  Humaira Ayub; Muhammad Imran Khan; Shazia Micheal; Farah Akhtar; Muhammad Ajmal; Sobia Shafique; Syeda Hafiza Benish Ali; Anneke I den Hollander; Asifa Ahmed; Raheel Qamar
Journal:  Mol Vis       Date:  2010-01-11       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.